Form 8-K Syndax Pharmaceuticals For: Jun 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Syndax raises $250 million through convertible notes offering
June 10, 2026 5:08 PM EDTSyndax Pharmaceuticals (NASDAQ: SNDX) completed a private placement of $250 million in convertible senior notes on June 10, according to a company filing. The 2.25% convertible senior notes are due in 2031.
The pharmaceutical company received net proceeds of approximately $243 million after deducting placement agent fees and offering... More
